The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India

Bhargava, Anurag; Shewade, Hemant Deepak

doi:10.1016/j.ijtb.2020.07.004

Cited by 69 publications

(78 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As COVID-19 began to spread rapidly across countries, several models predicted its impact on healthcare services, especially in low- and middle-income countries, where underfunded health services were barely coping with pre-pandemic public health needs ( Bhargava and Shewade, 2020 , Hogan et al, 2020 , McQuaid et al, 2020 , STOPTB PARTNERSHIP, 2020a ). Some of these modeling studies also included the effect of COVID-19 on TB services.…”

Section: Introductionmentioning

confidence: 99%

“…Some of these modeling studies also included the effect of COVID-19 on TB services. They predicted an increase in TB deaths of between 350,000 and 1.5 million deaths in 5 years deaths; as well as disruptions in case finding and treatment services ( Bhargava and Shewade, 2020 , Hogan et al, 2020 , McQuaid et al, 2020 , STOPTB PARTNERSHIP, 2020a ).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

TB and COVID – Public and private health sectors adapt to a new reality

Klinton¹,

Oga‐Omenka²,

Heitkamp³

2020

Journal of Clinical Tuberculosis and Other Mycobacterial Diseas

View full text Add to dashboard Cite

Health systems across the world have been baffled by the COVID19 pandemic. Tuberculosis (TB) care and prevention especially in high burden countries has faced disruption to their routine services. Though these setbacks were predicted by many modelling studies, reports and surveys from the field convey the hard reality faced by the TB services. However, health systems have not given up and have become resilient by adapting interesting strategies to overcome these obstacles. The private health sector has also stepped up to the occasion by supporting national TB programs through innovative approaches. The scientific community has laid down several evidence-based recommendations to help TB programs get back on track. Its time to unite these forces to not just overcome the challenge posed by the pandemic but also to build a more resilient health system.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

TB and COVID – Public and private health sectors adapt to a new reality

Klinton¹,

Oga‐Omenka²,

Heitkamp³

2020

Journal of Clinical Tuberculosis and Other Mycobacterial Diseas

View full text Add to dashboard Cite

show abstract

“…18 Another model estimate suggests that a 59% reduction in TB case detection between the end March and May 2020 may result in an estimated additional 87 711 TB deaths in 2020. 19 …”

Section: Large-scale Disruption Of Tb and General Health Servicesmentioning

confidence: 99%

India’s syndemic of tuberculosis and COVID-19

Shrinivasan¹,

Rane²,

Pai

2020

BMJ Glob Health

View full text Add to dashboard Cite

“…Movement restrictions are likely to interrupt access to health facilities and disrupt delivery of TB services such as community-based active case-finding, contact tracing, sputum transportation and distribution of essential commodities, even as the potential for community transmission increases. 39 Additionally, in many settings, TB patients are required to go to a health centre daily for directly observed therapy, which would be near impossible in a lock-down scenario. Thus, COVID-19 disruptions affect the TB service delivery system more than for most other conditions.…”

Section: Introductionmentioning

confidence: 99%

Commentary: Lessons from the COVID-19 global health response to inform TB case finding

Oga‐Omenka

Tseja-Akinrin²,

Boffa

et al. 2021

Healthcare

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) has emerged as a serious threat to global public health, demanding urgent action and causing unprecedented worldwide change in a short space of time. This disease has devastated economies, infringed on individual freedoms, and taken an unprecedented toll on healthcare systems worldwide. As of 1 April 2020, over a million cases of COVID-19 have been reported in 204 countries and territories, resulting in more than 51,000 deaths. Yet, against the backdrop of the COVID-19 pandemic, lies an older, insidious disease with a much greater mortality. Tuberculosis (TB) is the leading cause of death by a single infectious agent and remains a potent threat to millions of people around the world. We discuss the differences between the two pandemics at present, consider the potential impact of COVID-19 on TB case management, and explore the opportunities that the COVID-19 response presents for advancing TB prevention and control now and in future.

show abstract

The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India

Cited by 69 publications

References 19 publications

TB and COVID – Public and private health sectors adapt to a new reality

TB and COVID – Public and private health sectors adapt to a new reality

India’s syndemic of tuberculosis and COVID-19

Commentary: Lessons from the COVID-19 global health response to inform TB case finding

Contact Info

Product

Resources

About